Islay Capital Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-39
Closed -$987 – 233
2023
Q2
$987 Hold
39
– – ﹤0.01% 207
2023
Q1
$1.01K Sell
39
-750
-95% -$20.1K ﹤0.01% 213
2022
Q4
$18.7K Sell
789
-380
-33% -$10.2K 0.02% 171
2022
Q3
$30K Hold
1,169
– – 0.04% 169
2022
Q2
$39K Buy
1,169
+6
+0.5% +$255 0.04% 193
2022
Q1
$84K Sell
1,163
-495
-30% -$35.7K 0.07% 169
2021
Q4
$152K Buy
1,658
+353
+27% +$42.2K 0.11% 111
2021
Q3
$165K Buy
1,305
+115
+10% +$16.7K 0.13% 84
2021
Q2
$198K Sell
1,190
-265
-18% -$42.9K 0.16% 79
2021
Q1
$264K Buy
1,455
+123
+9% +$28.5K 0.22% 66
2020
Q4
$266K Buy
1,332
+200
+18% +$40.7K 0.24% 58
2020
Q3
$248K Hold
1,132
– – 0.26% 57
2020
Q2
$216K Sell
1,132
-1,110
-50% -$195K 0.25% 59
2020
Q1
$348K Sell
2,242
-1,548
-41% -$180K 0.46% 42
2019
Q4
$317K Buy
+3,790
New +$288K 0.3% 51

Other funds holding TDOC

Islay Capital Management's TDOC Position: Q3 2023 in Review

Islay Capital Management sold out of Teladoc Health (TDOC) in Q3 2023, closing a stake of 39 shares — an estimated $987 sold.

Islay Capital Management first reported a position in TDOC in Q4 2019 and held it in 15 quarters. The position peaked at $348K in Q1 2020. 436 funds tracked by Wall St. Rank hold TDOC as of Q3 2023.

  • Islay Capital Management reported no remaining Teladoc Health position as of Q3 2023 after selling out during the quarter.
  • Islay Capital Management sold 39 Teladoc Health shares in Q3 2023, an estimated $987.
  • Islay Capital Management first reported a position in Teladoc Health in Q4 2019 and held it in 15 quarters.
  • Islay Capital Management's Teladoc Health position peaked at $348K in Q1 2020.
  • 436 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2023.

Based on Islay Capital Management's 13F filing for Q3 2023, filed 2 Nov 2023.